Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2008
12/18/2008WO2008151845A2 Methods for producing glycosylated human alpha-1 antitrypsin (a1at) in mammalian host cells
12/18/2008WO2008151833A2 Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds
12/18/2008WO2008151526A1 A method of inducing taxane production
12/18/2008WO2008151440A1 Modifying glycoprotein production in plants
12/18/2008WO2008151390A1 Differentiation of human embryonic stem cells
12/18/2008WO2008151387A1 Method of initiating cardiomyocyte differentiation
12/18/2008WO2008151386A1 Megakaryocyte differentiation
12/18/2008WO2008124229A3 Improved bioreactor surfaces
12/18/2008WO2008109864A3 Functional nucleic acids for biological sequestration
12/18/2008WO2008109407A3 Extracellular matrix-derived gels and related methods
12/18/2008WO2008091680A3 Methods for controlling stem cell differentiation
12/18/2008WO2008091535A3 Antibodies to phosphorylated-irak4
12/18/2008WO2008086426A3 Methods for increasing and mobilizing hematopoietic stem cells
12/18/2008WO2008086296A3 Acid ceramidase and cell survival
12/18/2008WO2008063640A3 Use of bone marrow cells for long term culture of pancreatic islet cells
12/18/2008WO2008045286A3 Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
12/18/2008WO2008041004A3 Preparation method
12/18/2008WO2008030610A3 Human transcriptome corresponding to human oocytes and use of said genes or the corresponding polypeptides to trans-differentiate somatic cells
12/18/2008WO2008008814B1 Tissue transplantation compositions and methods
12/18/2008WO2008004990A3 Method for stem cell culture and cells derived therefrom
12/18/2008WO2008003042A3 Amnion-derived stem cells and uses thereof
12/18/2008WO2007146857A8 Anti- mcp-1 antibodies expressed in lemna, compositions, methods and uses
12/18/2008WO2007133665A3 Methods for collecting and using placenta cord blood stem cells
12/18/2008WO2007124493A3 Methods and compositions for producing recombinant proteins using a gene for trna
12/18/2008WO2007100722A3 Methods to identify factors associated with muscle growth and uses thereof
12/18/2008US20080313777 Secondary Wall Forming Genes From Maize and Uses Thereof
12/18/2008US20080313776 Soybean EF1A Promoter and Its Use in Constitutive Expression of Transgenic Genes in Plants
12/18/2008US20080313775 Nitrate reductases from red algae, compositions and methods of use thereof
12/18/2008US20080313773 Production of artificial micrornas using synthetic microrna precursors
12/18/2008US20080313772 The Rice Bentazon and Sulfonylurea Herbicide Resistant Gene Cyp81a6
12/18/2008US20080313771 Seed-specific gene promoters and uses thereof
12/18/2008US20080313769 EPSP synthase domains conferring glyphosate resistance
12/18/2008US20080313756 Plant quality traits
12/18/2008US20080313755 Squash Line ZGN 130-1028
12/18/2008US20080313753 Compositions and Methods for Improving Heart Function
12/18/2008US20080313752 Method for Differentiating Mesenchymal Stem Cells Into Steroid-Producing Cells
12/18/2008US20080313748 Transgenic Non-Human Animals Comprising the Human Udp-Glucuronosyltransferase 1A (Ugt1a) Gene Locus and Methods of Using Them
12/18/2008US20080313747 Targeted Transgenesis of Short Hairpin Rna Expression Cassettes Using Recombinase Mediated Cassette Exchange
12/18/2008US20080312426 Chicken leukemia inhibitory factor (LIF) and GNNE thereof
12/18/2008US20080312418 Antibody Specific for Human 4-1BB Receptor
12/18/2008US20080312417 Ucp5
12/18/2008US20080312416 Composite Materials Comprising Supported Porous Gels
12/18/2008US20080312412 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines
12/18/2008US20080312410 Cysteine-containing peptide tag for site-specific conjugation of proteins
12/18/2008US20080312409 antiapoptosis agents; transduction domains
12/18/2008US20080312329 Nonpeptide Inhibitors of Matrix Metalloproteinases
12/18/2008US20080312270 Compounds and methods useful for treating asthma and allergic inflammation
12/18/2008US20080312238 4-Arylazo-3,5-Diamino-Pyrazole Compounds and Use Thereof
12/18/2008US20080312202 6-substituted estradiol derivatives and methods of use
12/18/2008US20080312178 Human G-Protein Receptor HGBER32
12/18/2008US20080312176 Gene silencing
12/18/2008US20080312174 Water soluble crosslinked polymers
12/18/2008US20080312172 Anti-IL-6 Antibodies, Compositions, Methods and Uses
12/18/2008US20080312158 Semaphorin Gene Family
12/18/2008US20080312151 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone
12/18/2008US20080312148 the protein is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b)
12/18/2008US20080312146 METH1 and METH2 Polynucleotides and Polypeptides
12/18/2008US20080312143 Modified Cdna for High Expression Levels of Factor VIII and Its Derivatives
12/18/2008US20080312133 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
12/18/2008US20080312127 Host Cell Comprising a Vector for Production of Proteins Requiring Gamma-Carboxylation
12/18/2008US20080312093 Method for detecting cancer and a method for suppressing cancer
12/18/2008US20080311660 Dry powder cell culture products and methods of production thereof
12/18/2008US20080311659 Ribonucleic acid interference molecules of oryza sativa
12/18/2008US20080311658 Combined hairpin-antisense compositions and methods for modulating expression
12/18/2008US20080311657 Killing Human Lymphoma and Leukemia Cancer Cells and Tcr-Activated Normal Human Cells By Dopamine D1r Agonists
12/18/2008US20080311656 Meiosis arrest in oocytes in vitro
12/18/2008US20080311655 Heterodimeric fusion protein for use in the treatment of allergies and metastatic disease; cytokine linked to an antibody; nucleic acid encoding a fusion protein comprising an immunoglobulin (Ig) moiety linked by a peptide bond to the p35 subunit of interleukin-12
12/18/2008US20080311654 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens
12/18/2008US20080311653 Method and apparatus for regulating optimum flow of semen and separating motile sperms
12/18/2008US20080311652 Nucleic acids encoding Melanoma-associated antigen C2 (MAGE-C2); for provoking a cytolytic T cell response; for determining if a cell presents a Human Leukocyte Antigen(HLA) molecule on its surface; diagnostic and therapeutic assays; tumor monitoring
12/18/2008US20080311650 Bioreactor for Tissue Engineering
12/18/2008US20080311625 Immortal Pluripotent Stem Cell Line, Cell Lines Derived Therefrom, Methods of Preparing Thereof and Their Uses
12/18/2008US20080311624 Chimeric immunogens
12/18/2008US20080311623 Plasmid system for multigene expression
12/18/2008US20080311621 Polypeptides and nucleic acids encoding same
12/18/2008US20080311618 Expression System, Components Thereof and Methods of Use
12/18/2008US20080311612 Functional Expression of Higher Plant Nitrate Transporters in Pichia Pastoris
12/18/2008US20080311608 Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers
12/18/2008US20080311607 Methods and Compositions for Regulation of Stem Cell Survival, Proliferation, and Differentiation by Protein Ubiquitination
12/18/2008US20080311588 nucleotide sequences coding transcription factor for use as regulatory tools in nervous system development; Protein/transcription factor in basic-helix-loop-helix (bHLH) gene family which plays role in cell determination; genetic engineering
12/18/2008US20080311580 Novel genes encoding proteins involved in proanthocyanidin synthesis
12/18/2008US20080311552 Use of Sirnas in Organ Storage/Reperfusion Solutions
12/18/2008US20080311158 Hepatitis C Virus Replication System
12/18/2008US20080311155 Strain-Independent Amplification of Pathogens and Vaccines Thereto
12/18/2008US20080311149 DNA-transfection system for the generation of infectious influenza virus
12/18/2008US20080311148 DNA-transfection system for the generation of infectious influenza virus
12/18/2008US20080311144 Mutant forms of cholera holotoxin as an adjuvant
12/18/2008US20080311140 Antigen specific immunosuppression by dendritic cell therapy
12/18/2008US20080311137 Carcinoembryonic Antigen Fusions and Uses Thereof
12/18/2008US20080311132 Human Complement C3 Derivates with Cobra Venom Factor-Like Function
12/18/2008US20080311124 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders
12/18/2008US20080311123 Compositions and methods for the therapy and diagnosis of breast cancer
12/18/2008US20080311121 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability
12/18/2008US20080311120 Autocrine growth factor receptor antibodies and methods
12/18/2008US20080311111 Competitive Domain Antibody Formats That Bind Interleukin 1 Receptor Type 1
12/18/2008US20080311109 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders
12/18/2008US20080311108 Polypeptides
12/18/2008US20080311107 Novel Gene Disruptions, Compositions and Methods Relating Thereto
12/18/2008US20080311106 Product Comprising a C4bp Core Protein and a monomeric Antigen, and Its Use
12/18/2008US20080311102 Nucleic acid molecule that encodes the MGAT-X1 protein; pharmaceutical composition containing the nucleic acid or its expression vector